Ahead of earnings, Jim Cramer thinks you should know about this stock and the potential it presents.» Read More
Retail sales, at down 0.3 percent, was below expectations of a gain of 0.5 percent, though November was revised upward, while first time unemployment claims rose slightly more than expected for the week.
The Shanghai Index dropped 3.1 percent (Hong Kong down 2.6 percent) as China yesterday raised bank reserve requirements, which amounted to a tightening of monetary policy.
Shares of generic drugmaker Mylan dropped for the third straight session yesterday but drew heavy upside options activity.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
Stocks declined Wednesday as weak demand for today's Treasury auction and a sharp drop in oil prices dragged on the market. A disappointing durable-goods report didn't help either.
Stocks declined Wednesday after a report showed a much sharper drop in durable-goods orders than expected. Plus, a sharp selloff in China dragged on oil prices, which also weighed on the market.
Futures tumbled Wednesday after a report showed a much sharper drop in durable-goods orders than expected. Plus, a sharp selloff in China dragged on oil prices, which also weighed on the market.
Following are the day’s biggest winners and losers. Find out why shares of Watson Pharmaceuticals and Netflix popped while KeyCorp and Rio Tinto dropped.
The Lightning Round is extended in this CNBC.com exclusive feature.
The S&P 500 crossed above its 200-day moving average today for the first time since May 2008. As upward momentum builds in the markets, the here are fourteen companies that are near new highs.
Amid the gloom, Birinyi Associates' Cleve Rueckert found what he sees as a bright spot in the stock market. In a note, he says growth is the place to be, based on performance of the S&P's Pure Growth Index versus the S&P Pure Value Index. Here's his list of 15 stocks in the S&P 500 that fit three key growth criteria.
At the risk of offending our gracious hosts here at the Generic Pharmaceutical Association's Silver Anniversary Meeting, I wanted to talk about the seemingly incongruous venue for the event.
Despite the ongoing recession, generic drug makers like Teva Pharmaceutical and Watson Pharmaceutical have been outperforming in the broader market. CEOs William Marth and Paul Bisaro both expect to see further growth.
Cramer makes the call on viewers' favorite stocks.
Fast Money now – the plays you need while the market is still open
Options action on Watson Phamaceuticals indicates that traders think it might be a takeover target, according to one options experts
Cramer ventures a guess as to who's next on the takeover list.
arr's Chairman and CEO Bruce Downey told me Teva's CEO Schlomo Yanai made the first move. But it didn't happen in a long-distance phone call from Tel Aviv to New Jersey. They say they were at an industry conference in Palm Beach outside some burger joint when the subject came up.
Following are the day’s biggest winners and losers. Find out why shares of Delta Airlines and Office Depot popped while Energizer and Altria dropped.
Barr Pharmaceuticals said Wednesday quarterly earnings fell sharply, hurt by costs tied to an acquisition, but its operating profit beat Wall Street estimates as generic drug sales soared